Colorado is one of a handful of states with a review board for drug prices and one of only four with a board empowered to set ...

In 2024, the Colorado Prescription Drug Affordability Review Board declared Enbrel unaffordable, and last year it set an “upper payment limit” of about $31,000 per year.

Judge says Amgen likely to face significant, irreparable harm Enbrel price was capped at $31,200 annually, list price tops $100,000 Colorado declined to comment In granting a preliminary injunction, ...

In early June 2026, a federal judge granted Amgen a preliminary injunction blocking Colorado’s proposed 70% price cap on its rheumatoid arthritis drug Enbrel, while the company also initiated several ...

Earlier in July, a federal judge blocked Colorado’s plan to impose a 70% price cap on Amgen’s blockbuster arthritis drug ...

A Colorado board voted unanimously Feb. 16 to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted territory and setting up a possible showdown ...

A state board in Colorado is working to make history by becoming the first in the country to cap the price of a drug it deems unaffordable. Amid an aggressive industry lobbying campaign, Colorado ...

WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...